Clinical Trial Event in Maine Unites Patients, Governor and Industry in Fight Against Disease
The Research In Your Backyard (RIYB) event was a bright spot of hope amid an otherwise overcast day in Augusta, and PhRMA President and CEO (and longtime Maine resident) John Castellani spoke to his hometown crowd about the impact of clinical trials in Maine. With more than 560 clinical trials that have been conducted or are still occurring in the state in the past 13 years, the RIYB program provides an important message of hope to both patients and the state's economy. Read More...
The Value of Biopharmaceutical Innovation and New Drug Discovery
Biopharmaceutical innovation delivers far-reaching benefits to patients, the U.S. health care system and our state and national economies. New medicines discovered and developed by America’s biopharmaceutical research companies are helping people lead longer, more productive lives, controlling health care costs and stimulating the economy through high-quality jobs and a healthier workforce. Read More...
Medicine Safety
When it comes to medicines, safety has many meanings and many stakeholders: Volunteers in medical clinical trials, researchers and technicians working in laboratories and manufacturing facilities, regulators at the Food and Drug Administration (FDA), physicians prescribing medicines, and patients who rely on those therapies to lead healthier, longer lives—all have vested interests in safety. Read More...
